MapLight Therapeutics, Inc. MPLT 深 沪
交易中 03-26 11:34:58 美东时间
19.19
+1.050
+5.79%
华盛通- 最 高19.19
- 今 开17.62
- 成交量 3.12万股
- 最 低 17.62
- 昨 收 18.14
- 总市值 8.71亿
- 52周最高 21.55
- 市盈率 静 --
- 换手率 0.07%
- 52周最低 12.24
- 委 比 -81.92%
- 总股本 4537.30万
- 历史最高 21.55
- 量 比 0.35
- 振 幅 8.65%
- 历史最低 12.24
- 每 手 1
- 风险率 1.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
今天 19:11
MapLight Therapeutics Q4 EPS $(2.47) Misses $(0.96) Estimate
MapLight Therapeutics (NASDAQ:MPLT) reported quarterly losses of $(2.47) per share which missed the analyst consensus estimate of $(0.96) by 156.49 percent. This is a 91.16 percent increase over losses of $(27.95) per
今天 19:07
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
Canaccord Genuity Initiates Coverage On MapLight Therapeutics with Buy Rating, Announces Price Target of $35
Canaccord Genuity analyst Sumant Kulkarni initiates coverage on MapLight Therapeutics (NASDAQ:MPLT) with a Buy rating and announces Price Target of $35.
03-19 20:55
MapLight Therapeutics shares are trading lower. The company announced that it has updated the timing of its Phase 2 Schizophrenia and Autism data readouts to the third quarter of 2026.
MapLight Therapeutics shares are trading lower. The company announced that it h...
01-14 03:29
The FDA Has Granted Fast Track Designation To MapLight Therapeutics' ML-007C-MA For Hallucinations And Delusions Associated With Alzheimer's Disease Psychosis
In a Phase 1 clinical trial, ML-007C-MA demonstrated a generally favorable safety and tolerability profile with twice daily dosing in healthy elderly participants. Enrollment is currently ongoing in the Phase 2 VISTA
01-05 20:25
SandboxAQ And MapLight Therapeutics Collaborate To Discover And Develop Therapies Targeting G Protein-Coupled Receptor For Treatment Of Central Nervous System Disorders
SandboxAQ and MapLight Therapeutics, Inc. (NASDAQ:MPLT) announced today that the companies have entered into a strategic collaboration to discover and develop potential first-in-class therapies targeting a novel G
2025-12-16 20:05
MapLight Therapeutics Q3 EPS $(37.18) Misses $(1.55) Estimate
MapLight Therapeutics (NASDAQ:MPLT) reported quarterly losses of $(37.18) per share which missed the analyst consensus estimate of $(1.55) by 2291 percent. This is a 48.25 percent decrease over losses of $(25.08) per
2025-12-04 21:06
美股牛股 | 机器人概念股集体爆发！iRobot涨超73%，Richtech Robotics涨超18%；医药股Capricor暴涨超371%
机器人概念股集体爆发！iRobot涨超73%，Richtech Robotics涨超18%，特朗普新政拟All in 机器人；医药股Capricor暴涨超371%，关键实验获重大突破>>
2025-12-04 15:42
Marvell Posts Strong Q3 Earnings, Joins American Eagle, Microchip Technology, Box And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones gaining around 100 points on Wednesd...
2025-12-03 23:16
